During the corresponding time, Dynavax Technologies Corporation recorded a revenue increase by 17.67 % year on year, sequentially revenue fell by -0.59 %. While revenue at the Dynavax Technologies Corporation's corporate clients
Dynavax Technologies's Comment on Sales, Marketing and Customers
The company targets customers with the highest impact on adult hepatitis B vaccine utilization in the U.S., deploying its sales force to physicians, pharmacists, and procurement levels within healthcare segments where vaccines are used. It focuses on increasing market share and size over time. The company conducted a study on HEPLISAV-B for adults with end-stage renal disease undergoing hemodialysis and is seeking FDA approval for this use, aiming to include dialysis centers in its promotion efforts. Additionally, the company collaborates with vaccine developers to evaluate CpG 1018 adjuvanted vaccine candidates against influenza, other infectious diseases, and COVID-19 across various platforms.
Dynavax Technologies’s Comment on Sales, Marketing and Customers
The company targets customers with the highest impact on adult hepatitis B vaccine utilization in the U.S., deploying its sales force to physicians, pharmacists, and procurement levels within healthcare segments where vaccines are used. It focuses on increasing market share and size over time. The company conducted a study on HEPLISAV-B for adults with end-stage renal disease undergoing hemodialysis and is seeking FDA approval for this use, aiming to include dialysis centers in its promotion efforts. Additionally, the company collaborates with vaccine developers to evaluate CpG 1018 adjuvanted vaccine candidates against influenza, other infectious diseases, and COVID-19 across various platforms.
Sources:
Dynavax Technologies Corporation’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Dynavax Technologies Corporation’s corporate clients.
For your research, we’ve provided 9 tables on Dynavax Technologies Corporation corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
100 %